For research use only. Not for therapeutic Use.
Thiocarlide (isoxyl) is a thiourea derivative that was used in the 1960s to successfully treat tuberculosis (TB). It has considerable antimycobacterial activity <em>in vitro</em> and is effective against multi-<wbr></wbr>drug resistant strains of <em>Mycobacterium tuberculosis</em> in the range of 1-<wbr></wbr>10 µg/ml. At concentrations of 10 µM, isoxyl inhibits the synthesis of <em>M. bovis</em> during six hours of exposure which is similar to isoniazid (INH) and ethionamide (ETH), two other predominant anti-<wbr></wbr>tuberculosis drugs. Unlike INH and ETH, isoxyl also partially inhibits the synthesis of fatty acids. Isoxyl shows no acute toxicity against primary macrophage cell cultures as demonstrated by diminution of redox activity.
Catalog Number | R012085 |
CAS Number | 910-86-1 |
Synonyms | Isoxyl |
Molecular Formula | C23H32N2O2S |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | 1,3-bis[4-(3-methylbutoxy)phenyl]thiourea |
InChI | InChI=1S/C23H32N2O2S/c1-17(2)13-15-26-21-9-5-19(6-10-21)24-23(28)25-20-7-11-22(12-8-20)27-16-14-18(3)4/h5-12,17-18H,13-16H2,1-4H3,(H2,24,25,28) |
InChIKey | BWBONKHPVHMQHE-UHFFFAOYSA-N |
SMILES | CC(C)CCOC1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)OCCC(C)C |
Reference | 1.Phetsuksiri, B.,Jackson, M.,Scherman, H., et al. Unique mechanism of action of the thiourea drug isoxyl on mycobacterium tuberculosis. The Journal of Biological Chemisty 278(52), 53123-53130 (2003). |